BPA for tracleer, zavesca, ventavis, veletri, opsumit, uptravi, opsynvi
Active Awarded Last action
- Contract number
- 36E79724A0029
- Awardee
-
Actelion Pharmaceuticals US, Inc. UEI H5BMHLMMNA28
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 73% complete
- IDV ceiling
- $118,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The National Acquisition Center established a single-award Blanket Purchase Agreement with Actelion Pharmaceuticals US, Inc. on August 22, 2024, with a ceiling of $118.5 million and ultimate completion date of August 21, 2027. The BPA is structured against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and covers seven pharmaceutical products: Tracleer, Zavesca, Ventavis, Veletri, Opsumit, Uptravi, and Opsynvi. These medications serve rare disease indications, particularly pulmonary arterial hypertension treatments, procured for federal healthcare institutions including the Department of Veterans Affairs and the Federal Bureau of Prisons.
The BPA enables authorized federal agencies to place delivery orders nationwide using pre-negotiated pricing that incorporates annual Public Law pricing updates. This vehicle replaced a prior BPA valued at $83.5 million (May 2024–May 2025) and reflects updated pricing and procurement requirements. Delivery orders under this and predecessor agreements have been issued by Veterans Integrated Service Networks and Federal Bureau of Prisons facilities across the federal government's network of medical centers and correctional institutions, with individual orders historically ranging from approximately $1,350 to $676,582.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79724A0029?
36E79724A0029 was awarded to Actelion Pharmaceuticals US, Inc. by National Acquisition Center (Headquarters) on August 22, 2024.
How much is contract 36E79724A0029 worth?
36E79724A0029's own ceiling is $118,500,000.
Who can order from contract 36E79724A0029?
36E79724A0029 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79724A0029 under another contract?
Yes. 36E79724A0029 is a blanket purchase agreement under 36F79724D0159, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79724A0029 competed?
The extent of competition for 36E79724A0029 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV